Yunnan Hongxiang Yixintang
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, sanitary products and disposable medical products, household appliances, adult toys, agricultura… Read more
Market Cap & Net Worth: Yunnan Hongxiang Yixintang (002727)
Yunnan Hongxiang Yixintang (SHE:002727) has a market capitalization of $1.05 Billion (CN¥7.68 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #9830 globally and #2079 in its home market, demonstrating a -0.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yunnan Hongxiang Yixintang's stock price CN¥13.11 by its total outstanding shares 585604125 (585.60 Million).
Yunnan Hongxiang Yixintang Market Cap History: 2015 to 2026
Yunnan Hongxiang Yixintang's market capitalization history from 2015 to 2026. Data shows change from $2.07 Billion to $1.05 Billion (-5.17% CAGR).
Yunnan Hongxiang Yixintang Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yunnan Hongxiang Yixintang's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Yunnan Hongxiang Yixintang's market cap is 0.06 times its annual revenue
8.52x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
9.10x
Yunnan Hongxiang Yixintang's market cap is 9.10 times its annual earnings
1.34x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.07 Billion | $5.32 Billion | $346.26 Million | 0.39x | 5.98x |
| 2016 | $1.53 Billion | $6.25 Billion | $353.38 Million | 0.25x | 4.34x |
| 2017 | $1.47 Billion | $7.75 Billion | $422.71 Million | 0.19x | 3.47x |
| 2018 | $1.31 Billion | $9.18 Billion | $521.07 Million | 0.14x | 2.52x |
| 2019 | $1.73 Billion | $10.48 Billion | $603.92 Million | 0.17x | 2.87x |
| 2020 | $2.51 Billion | $12.66 Billion | $789.96 Million | 0.20x | 3.18x |
| 2021 | $2.92 Billion | $14.59 Billion | $921.58 Million | 0.20x | 3.17x |
| 2022 | $2.43 Billion | $17.43 Billion | $1.01 Billion | 0.14x | 2.41x |
| 2023 | $1.81 Billion | $17.38 Billion | $549.44 Million | 0.10x | 3.30x |
| 2024 | $1.04 Billion | $18.00 Billion | $114.14 Million | 0.06x | 9.10x |
Competitor Companies of 002727 by Market Capitalization
Companies near Yunnan Hongxiang Yixintang in the global market cap rankings as of March 18, 2026.
Key companies related to Yunnan Hongxiang Yixintang by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Yunnan Hongxiang Yixintang Historical Marketcap From 2015 to 2026
Between 2015 and today, Yunnan Hongxiang Yixintang's market cap moved from $2.07 Billion to $ 1.05 Billion, with a yearly change of -5.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.05 Billion | +1.94% |
| 2025 | CN¥1.03 Billion | -1.23% |
| 2024 | CN¥1.04 Billion | -42.71% |
| 2023 | CN¥1.81 Billion | -25.40% |
| 2022 | CN¥2.43 Billion | -16.86% |
| 2021 | CN¥2.92 Billion | +16.42% |
| 2020 | CN¥2.51 Billion | +44.82% |
| 2019 | CN¥1.73 Billion | +32.34% |
| 2018 | CN¥1.31 Billion | -10.71% |
| 2017 | CN¥1.47 Billion | -4.27% |
| 2016 | CN¥1.53 Billion | -25.95% |
| 2015 | CN¥2.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Yunnan Hongxiang Yixintang was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.05 Billion USD |
| MoneyControl | $1.05 Billion USD |
| MarketWatch | $1.05 Billion USD |
| marketcap.company | $1.05 Billion USD |
| Reuters | $1.05 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.